Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in cancer and genetic disorders, today announced that Christian Hofmann, Ph.D., has been appointed as the company’s Chief Executive Officer and member of the board of directors. “Since the launch…


ADVERTISEMENT — Advertise With Biotech Networks